Precigen (PGEN) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $171.3 million.
- Precigen's Liabilities and Shareholders Equity rose 10517.05% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $547.2 million, marking a year-over-year increase of 2365.72%. This contributed to the annual value of $145.3 million for FY2024, which is 382.47% down from last year.
- As of Q3 2025, Precigen's Liabilities and Shareholders Equity stood at $171.3 million, which was up 10517.05% from $101.9 million recorded in Q2 2025.
- Over the past 5 years, Precigen's Liabilities and Shareholders Equity peaked at $407.0 million during Q1 2021, and registered a low of $73.2 million during Q2 2024.
- Moreover, its 5-year median value for Liabilities and Shareholders Equity was $207.5 million (2023), whereas its average is $226.7 million.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first tumbled by 6474.68% in 2024, then soared by 10517.05% in 2025.
- Precigen's Liabilities and Shareholders Equity (Quarter) stood at $359.9 million in 2021, then tumbled by 39.98% to $216.0 million in 2022, then crashed by 30.07% to $151.0 million in 2023, then fell by 3.82% to $145.3 million in 2024, then rose by 17.9% to $171.3 million in 2025.
- Its last three reported values are $171.3 million in Q3 2025, $101.9 million for Q2 2025, and $128.8 million during Q1 2025.